No Data
Research Reports: Guosen maintains the "Outperform Market" rating for Marnie Bio, with multi-brand iterations supporting long-term growth.
The Guosen Research Reports indicate that Marubi Biotechnology (603983.SH) has undergone more than three years of adjustments and transformations, and has now revitalized its established domestic beauty brand. The main brand Marubi relies on the company's long-term research and development in the eye cream and restructured collagen sectors, and has successfully transformed through online channels, leveraging Technology and emotional marketing to deeply reach young consumers. It has successfully created two major series of products, the Little Red Pen and the Little Gold Needle, and is currently in a phase of product momentum explosion. Meanwhile, the emerging base makeup brand Lianhuo tightly grasps consumer pain points in base makeup, achieving breakthroughs through content marketing and top influencers, while continuously upgrading core products and extending into new categories.
Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) 31% Share Price Surge Not Quite Adding Up
GTJA: WeChat mini-stores "gifting" open new scenarios, with snacks and beauty products expected to benefit.
Referring to the rapid popularization of WeChat Pay after the introduction of WeChat red envelopes, the gifting function is expected to help open a new traffic entrance for the WeChat e-commerce system and assist in user conversion.
Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?
guangdong marubi biotechnology (603983.SH): Intends to change the securities abbreviation to "Marubi Biology".
Gelonghui December 5th | guangdong marubi biotechnology (603983.SH) announced that the company held the fifth session of the board of directors on December 5, 2024, to deliberate and approve the proposal on the proposed change of the company's stock abbreviation, agreeing to change the company's stock abbreviation from "guangdong marubi biotechnology" to "guangdong marubi biology", while the company's stock code "603983" remains unchanged.
Guosen: The wave of mergers and acquisitions in the retail industry is rising, an important growth paradigm for enterprises in the era of existing inventory.
From the perspective of leading listed companies, a significant amount of capital operation and diversified management experience has been accumulated in recent years. With the increasing demand for exits in the primary market, many high-quality consumer symbols have also provided listed companies with good acquisition and integration opportunities.
Guangdong Marubi Biotechnology (SHSE:603983) May Have Issues Allocating Its Capital
